[HTML][HTML] Reference intervals for serum osteocalcin concentrations in adult men and women from the study of health in Pomerania

A Hannemann, N Friedrich, C Spielhagen… - BMC endocrine …, 2013 - Springer
A Hannemann, N Friedrich, C Spielhagen, R Rettig, T Ittermann, M Nauck, H Wallaschofski
BMC endocrine disorders, 2013Springer
Background Osteocalcin (OC) is a bone-specific protein produced primarily by osteoblasts
during bone formation. Besides its role in bone formation, osteocalcin may play a role in the
regulation of energy metabolism and male fertility. To interpret serum OC data, reference
intervals adapted to a specific laboratory method are needed. Methods A healthy reference
population was selected from the first follow-up of the Study of Health in Pomerania. Serum
OC concentrations were measured with the IDS-iSYS N-Mid Osteocalcin assay on the IDS …
Background
Osteocalcin (OC) is a bone-specific protein produced primarily by osteoblasts during bone formation. Besides its role in bone formation, osteocalcin may play a role in the regulation of energy metabolism and male fertility. To interpret serum OC data, reference intervals adapted to a specific laboratory method are needed.
Methods
A healthy reference population was selected from the first follow-up of the Study of Health in Pomerania. Serum OC concentrations were measured with the IDS-iSYS N-Mid Osteocalcin assay on the IDS-iSYS Automated System (Immunodiagnostic Systems, Frankfurt am Main, Germany). The reference interval was defined as the central 95% range (2.5th-97.5th percentile). Age-specific reference intervals were calculated by quantile regression for 1107 men (25–79 years) and 545 premenopausal women (25–54 years). The reference interval for 498 postmenopausal women (50–79 years) was calculated irrespective of age.
Results
Median (1st-3rd quartile) serum OC concentrations were 15.4 ng/mL (12.0-19.4 ng/mL) in men, 14.4 ng/mL (11.3-18.5 ng/mL) in premenopausal women, and 18.6 ng/mL (13.6-25.6 ng/mL) in postmenopausal women. Serum OC concentrations were highest in men and premenopausal women aged 25–29 years, were stable during midlife, and rose again after 65 years of age in men and at transition to menopause in women. Serum OC concentrations were lower in women taking oral contraceptives or who were under hormone replacement therapy after menopause and in subjects with diabetes mellitus or with body mass index < 18 or > 30 kg/m2 than in subjects without these conditions.
Conclusions
We established sex-specific adult reference intervals for the serum OC concentration measured by the IDS-iSYS N-Mid Osteocalcin assay.
Springer